Clerbaux, L.-A.; Filipovska, J.; Muñoz, A.; Petrillo, M.; Coecke, S.; Amorim, M.-J.; Grenga, L.
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. J. Clin. Med. 2022, 11, 5400.
https://doi.org/10.3390/jcm11185400
AMA Style
Clerbaux L-A, Filipovska J, Muñoz A, Petrillo M, Coecke S, Amorim M-J, Grenga L.
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. Journal of Clinical Medicine. 2022; 11(18):5400.
https://doi.org/10.3390/jcm11185400
Chicago/Turabian Style
Clerbaux, Laure-Alix, Julija Filipovska, Amalia Muñoz, Mauro Petrillo, Sandra Coecke, Maria-Joao Amorim, and Lucia Grenga.
2022. "Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways" Journal of Clinical Medicine 11, no. 18: 5400.
https://doi.org/10.3390/jcm11185400
APA Style
Clerbaux, L.-A., Filipovska, J., Muñoz, A., Petrillo, M., Coecke, S., Amorim, M.-J., & Grenga, L.
(2022). Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. Journal of Clinical Medicine, 11(18), 5400.
https://doi.org/10.3390/jcm11185400